Last reviewed · How we verify
NCT03777046: MMH
Maternal Mental Health in the Hospital Setting
NA trial testing Standard of Care (SOC) in Post Partum Depression in 545 participants. Completed in 22 May 2020.
13 March 2020
Quick facts
| Lead sponsor | Michelle Lopez |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 545 |
| Start date | 24 January 2019 |
| Primary completion | 13 March 2020 |
| Estimated completion | 22 May 2020 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Standard of Care (SOC) — full drug profile →
- SOC with Psychology Therapy (CBT)
Conditions studied
- Post Partum Depression — all drugs for Post Partum Depression →
Sponsor
Michelle Lopez
Who can join
18 and older, female only, with Post Partum Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Perinatal (around the time of birth) mental health disorders are common difficulties of pregnancy. Perinatal depression is made up of major and minor depressive events during pregnancy and the first 12 months after delivery. It is estimated that 11%-19% of mothers suffer from perinatal depression. However, rates may be significantly higher among some subpopulations. Left untreated, post partum depression (PPD) is linked with several significant negative health impacts on the mother, her infant, and their families. PPD is linked with lower quality maternal-child relationship, and this change in emotional attachment can lead to physiologic changes and poorer cognitive outcomes in the infant. The purpose of this study is to determine the maternal mental health effect of postpartum depression screening and intervention during infants' short term hospitalizations. The study is also aiming to define effects of PPD short term hospitalization interventions on maternal PPD follow up and child health based on well child care (WCC), emergency department (ED) visits, hospital readmissions, and parent's feelings on child's health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03777046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard of Care (SOC)
Trials testing the same drug.
- NCT07415577 — The Use of Cultured (Dermal) Epithelial Autografts in Severely Burned Patients · not yet recruiting
- NCT07329946 — Immuno-inflammatory Response of Erdosteine in COPD · NA · not yet recruiting
- NCT07461961 — CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock · Phase 2 · not yet recruiting
- NCT07227909 — NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy · Phase 2 · not yet recruiting
- NCT07379684 — A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections · Phase 1 · recruiting
Other recruiting trials for Post Partum Depression
Currently open trials in the same condition.
- NCT06991166 — OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression · NA · recruiting
- NCT06968390 — Accelerated TMS for Perinatal Depression · NA · recruiting
- NCT05268588 — mHealth India Postnatal Health Intervention Effectiveness · NA · recruiting
- NCT06253676 — Sensing Technologies for Maternal Depression Treatment in Low-Resource Settings · NA · recruiting
- NCT04845230 — Fresh RX: NHS 2020 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03777046 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Michelle Lopez
- Last refreshed: 14 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03777046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing